Showing results (51-60 of 85) with videos related to
Sort By:
Pageof 9
Frontiers in Immunology|August 4, 2018
Inflammasome Priming Mediated via Toll-Like Receptors 2 and 4, Induces Th1-Like Regulatory T Cells in De Novo Autoimmune HepatitisAdam S Arterbery, Jie Yao, Andrew Ling, et al.Dalton Transactions (Cambridge, England : 2003)|October 8, 2009
A novel route to rhodaboratranes [Rh(CO)(PR3){B(taz)3}]+ via the redox activation of scorpionate complexes [RhLL'Tt]Robin J Blagg, Christopher J Adams, Jonathan P H Charmant, et al.Research Square|April 2, 2024
Auto-sumoylation of the Ubc9 E2 SUMO-conjugating Enzyme Extends Cellular LifespanHong-Yeoul Ryu, Dong-Won Jeong, Seung Yeon Kim, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2014
Imaging DNA damage allows detection of preneoplasia in the BALB-neuT model of breast cancerBart Cornelissen, Sarah Able, Christiana Kartsonaki, et al.Genes, Chromosomes & Cancer|August 24, 2018
Clonal evolution analysis of paired anaplastic and well-differentiated thyroid carcinomas reveals shared common ancestorWeilai Dong, Norman G Nicolson, Jungmin Choi, et al.Nature Communications|April 20, 2025
Auto-sumoylation of the yeast Ubc9 E2 SUMO-conjugating enzyme extends cellular lifespanDong-Won Jeong, Do Yoon Lee, Seung Yeon Kim, et al.Genes|August 28, 2025
Copy Number Variants of Uncertain Significance by Chromosome Microarray Analysis from Consecutive Pediatric Patients: Reevaluation Following Current Guidelines and Reanalysis by Genome SequencingWenjiao Li, Xiaolei Xie, Hongyan Chai, et al.Acta Neurochirurgica|July 13, 2022
Prognostic factors for surgically managed intramedullary spinal cord tumours: a single-centre case seriesAsfand Baig Mirza, Axumawi Gebreyohanes, James Knight, et al.Oncogene|August 30, 2025
LZTR1 is a melanoma oncogene that promotes invasion and suppresses apoptosisAntonella Bacchiocchi, Michael Mak, Zerin Mahzabin Khan, et al.Aging|February 20, 2025
Transcriptomic landscape of cumulus cells from patients <38 years old with a history of poor ovarian response (POR) treated with platelet-rich plasma (PRP)Leah M Roberts, Nola Herlihy, Andres Reig, et al.Pageof 9